Meta-Analysis
Copyright ©The Author(s) 2018.
World J Gastroenterol. Apr 21, 2018; 24(15): 1658-1665
Published online Apr 21, 2018. doi: 10.3748/wjg.v24.i15.1658
Table 2 Demographic and clinical aspects of the selected studies
Ref.nAgeMale gender (%)waiting time (mo)MELDUnderlying diseaseMajor lesion diam (cm)Number lesionsMC-OUT (%)AFP ≥ 200 ng/mL (%)LRT (%)Cut-offAUROC> cut-off (%)Recurr (%)5-yr TFS
Xia et al[24]34349 ± 10308 (90)NA13 ± 6HBV = 320> 5:110> 3:91199 (58)165 (48)222 (65)1500.6333 (10)NA< 150: 52
Other = 23≥ 150:25
Lai et al[25]14658 (54-63)116 (80)8 (3-10)11 (8-11)HCV = 632.5 (1.7-3.5)1 (1-2)32 (22)8 (6)136 (93)1500.6628 (19)14 (10)< 150:92
HBV = 26≥ 150:81
Other = 57
Parisi et al[26]15054 ± 7125 (83)2 (0-12)NAHCV = 602.710 (-)13 (9)71 (47)150NA17 (11)19 (13)NA
HBV = 34
Other = 56
Nicolini et al[27]7057 (51-62)62 (89)NA11 (7-15)HCV = 411.3 (0.0-2.1)1 (0-2)12 (17)6 (9)170 (100)150NA5 (7)8 (11)< 150:89
HBV = 15≥ 150:50
Other = 14
Harimoto et al[28]190≥ 59:97107 (56)NA≥ 15:60HCV = 134> 5:8> 3:4166 (35)30 (16)2NA70.40.7097 (51)28 (15)< 70.4:95
Other = 56≥ 70.4:76